Eklira Genuair

Eklira Genuair

Manufacturer:

AstraZeneca

Distributor:

Zuellig
/
Four Star
Concise Prescribing Info
Contents
Aclidinium Br
Indications/Uses
Maintenance bronchodilator treatment to relieve symptoms in adult patients w/ COPD.
Dosage/Direction for Use
Special Precautions
May cause paradoxical bronchospasm. Should not be used for relief of acute episodes of bronchospasm ie, as a rescue therapy. Anticholinergic activity. Use w/ caution in patients w/ MI during the previous 6 mth, unstable angina, newly diagnosed arrhythmia w/in the previous 3 mth, or hospitalisation w/in the previous 12 mth for heart failure functional NYHA classes III & IV; patients w/ symptomatic prostatic hyperplasia or bladder-neck obstruction or narrow-angle glaucoma. Dry mouth may in the long term be associated w/ dental caries. Rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Minor influence on the ability to drive & use machines. Pregnancy & lactation.
Adverse Reactions
Headache; nasopharyngitis, sinusitis; cough; diarrhoea, nausea.
Drug Interactions
Not recommended w/ other anticholinergic-containing drugs.
MIMS Class
Antiasthmatic & COPD Preparations
ATC Classification
R03BB05 - aclidinium bromide ; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, anticholinergics.
Presentation/Packing
Form
Eklira Genuair inhalation powd 322 mcg
Packing/Price
1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in